PTPRB and COVID-19: In our study, 2 unrelated approaches to Tie2 activation, direct Tie2 agonism with Angpt-1 and VE-PTP antagonism with AKB-9778, inhibit thromboinflammatory changes in endothelial cells induced by plasma from patients with COVID-19.